Table 3 Step-wise multiple regression analysis between overall survival and clinical parameters
From: Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs
Variable | Standardized regression coefficient | F | P value | Change in R2 |
|---|---|---|---|---|
Age | - | 0.042 | 0.840 | 0.604 |
Sex | -108.81 | 4.883 | 0.037 | 0.431 |
EGFR mutation status | -164.64 | 9.954 | 0.004 | 0.258 |
Stage | - | 1.093 | 0.307 | 0.604 |
IL-8 level at diagnosis | - | 0.001 | 0.973 | 0.604 |
IL-10 level at diagnosis | 3.30 | 3.726 | 0.066 | 0.584 |
RANTES level at diagnosis | -0.15 | 4.453 | 0.045 | 0.517 |